Clinical trial · Observational
Cross-sectional and Questionnaire Study for Leg Lymphedema
The Cross-sectional and Questionnaire Study of Pelvic and Lower Extremity Lymphedema After Treatment of Gynecological Disease
NCT02069171CI-TRIAL-00013843completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to identify the incidence,feature,clinical significance for leg lymphedema after gynecologic cancer treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- early ovarian cancer group
- label
- locally advanced cervical cancer group
- label
- primary endometrial cancer group
Primary outcomes (1)
- measure
- Gynecologic Cancer Lymphedema Questionnaire
- timeFrame
- The study outcome measure will be assessed by telephone interview , one time.
- description
- There are no more follow up except one time telephone interview.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
* Inclusion criteria 1. the patient who gynecologic cancer treatment at National Cancer Center , Korea(2001\~2011) 2. no active cancer treatment at the moment 3. available telephone communication * exclusion criteria 1. The patient unlikely to comply with the protocol \<More information by cancer type\> * early ovarian cancer group Inclusion criteria were early stage epithelial ovarian cancer\*, no active treatment, available telephone communication with patients, and ability and willingness to provide verbal informed consent. \*early ovarian cancer (FIGO stage I and II) at National Cancer Center, Korea who underwent cytoreductive and staging surgery between January 2001 and December 2010 * locally advanced cervical cancer group patients with locally advanced cervical cancer who treatment at National Cancer Center, Korea between October 2001 and July 2007. Of 222 patients with locally advanced cervical cancer, 74 patients were underwent pretreatment laparoscopic surgical staging and 148 patients received radiotherapy . Women with locally advanced cervical cancer, no active treatment at survey, available telephone communication, and ability and willingness to provide verbal informed consent were considered to include in the current study. * primary endometrial cancer group patients with endometrial cancer who underwent surgery, no active treatment at survey, available telephone communication, and ability and willingness to provide verbal informed consent were considered to include in the current study
References
Publications (0)
Data not yet available
No reference posted for this study.